Prescription Privileges

1: Prescription Privileges Some of the current changes that can be seen in regards to prescription privileges include changes in the ways that physicians and mental health professionals are able to prescribe medications to their patients. According to Brenda Smith of the APA (2012), currently patients receive their medications for psychological conditions by a physician usually without having been evaluated by a mental health practitioner according to the CDC.
The trend includes individuals to visit their general health practitioners in order to receive psychotropic medications such as antidepressants and anxiolytics. The problem with individuals receiving these medications from other sources include: deterrence from alternate treatment interventions that include CBT or psychoanalysis.
Changes currently described as happening in the realm of prescription privileges include the expansion of prescription writing privileges to mental health professional such as license psychologists that are well-versed in psychopharmacology as well as the dangers of overuse and over prescription of psychotropic medications. According to the American psychological Association (Smith, 2012), several states programs for psychologists designed in respect to prescription privileged programs have been approved.The states include Louisiana, New Mexico and the US armed forces. Additionally according to the American psychological Association (Smith, 2012), there are several bills being considered in many other states regarding the expansion of prescription drug privileges but many of these measures have been met by opposition from the American Medical Association and the American psychiatric Association due to concerns about the adequacy of each training programs in dispensing of prescription medication and overall patient safety. . Changes in Ethics of Drug Treatment Some of the decisive changes described above in the ethical use of drug treatments for individuals that might have a psychological disorder include the consideration of clinical level testing for psychotropic medication prescription. Special attention should be giving to understanding informed consent and any challenges that may be presented and prescribing ethically medications to special populations such as children.
According to the Gerald Tietz of the Washington law review (1986), indicates that it is well within a practitioner’s scope of duty to inform the patient of significant effects were injuries that may be related to the prescribing of any particular pharmacological treatment. This informed consent should be expanded to include the harms were dangerous presented also with non-use of additional treatment interventions such as therapy or CBT.
Additional trends identified in ambulance pediatrics (Cooper, Arbogast & Ding, 2006), or the trends and the prescription of antipsychotic medications for children in the United States of America. The information taken from the national ambulatory medical care survey in regards to the US population indicated that between 1995 and 2002 there were nearly 6,000,000 visits to health providers by children in the US that had been subscribed or prescribed antipsychotic medications.
Nearly 1/3 of the prescriptions for lease populations were provided by non-mental health service professionals. The study of the department of pediatrics at Vanderbilt University in Nashville also indicated that over half of the prescriptions for these children were given based on behavioral indications or affective disorders which find a way have not been fully studied for use in children.
These changes tend to speak more towards the trends and blocking of measures to expand prescription privileges due to the fact that they affect children as a special group. It appears that the special groups and factors such as overprescribing of psychotropic medications fueled a change in the ethics of drug treatment. As these factors become rectified, so will be trends were changes towards allowing privilege of prescription to mental health professionals and expansion of ethical considerations for those individuals prescribing these drugs.
Approximate price: $22
We value our customers and so we ensure that what we do is 100% original..

With us you are guaranteed of quality work done by our qualified experts.Your information and everything that you do with us is kept completely confidential.You have to be 100% sure of the quality of your product to give a money-back guarantee. This describes us perfectly. Make sure that this guarantee is totally transparent.The Product ordered is guaranteed to be original. Orders are checked by the most advanced anti-plagiarism software in the market to assure that the Product is 100% original. The Company has a zero tolerance policy for plagiarism.The Free Revision policy is a courtesy service that the Company provides to help ensure Customer’s total satisfaction with the completed Order. To receive free revision the Company requires that the Customer provide the request within fourteen (14) days from the first completion date and within a period of thirty (30) days for dissertations.The Company is committed to protect the privacy of the Customer and it will never resell or share any of Customer’s personal information, including credit card data, with any third party. All the online transactions are processed through the secure and reliable online payment systems.By placing an order with us, you agree to the service we provide. We will endear to do all that it takes to deliver a comprehensive paper as per your requirements. We also count on your cooperation to ensure that we deliver on this mandate.